MEDTRONIC SOFAMOR DANEK USA, INC INFUSE BONE GRAFT; FILLER, RECOMBINANT HUMAN BONE MORPHOGENETIC PROTEIN, COLLAGEN SCAFFOLD WITH MET
|
Back to Search Results |
|
Device Problem
Adverse Event Without Identified Device or Use Problem (2993)
|
Patient Problems
Ossification (1428); Inflammation (1932); Neuropathy (1983); Pain (1994); Swelling (2091); Dysphasia (2195); Neck Pain (2433)
|
Event Type
Injury
|
Event Description
|
It was reported that the patient underwent a c5-c6 bilateral laminectomy with fusion using competitor screw system, bone morphogenic protein, and spinal microdissection.Reportedly, sometime post-op, imaging studies showed that the patient had developed uncontrolled bone growth and nerve compression at or near where rhbmp-2/acs was implanted.The patient experienced uncontrolled or ectopic bone growth, cervical spine pain, swelling of airways, difficulty speaking, inflammatory reactions, pain to other parts of her body, chronic pain and radiculitis.
|
|
Manufacturer Narrative
|
Concomitant medical products: synthes lateral mass screw system (implant (b)(6) 2010; explant unknown).(b)(4).Neither the device nor applicable imaging study films or patient medical records were returned to the manufacturer for evaluation.Therefore, we are unable to determine the definitive cause of the reported event.Products from multiple manufacturers were implanted/used during the procedure.Although it is unknown if any of the devices contributed to the reported event, we are filing this mdr for notification purposes.
|
|
Manufacturer Narrative
|
A good faith effort will be made to obtain the applicable information relevant to the report.If information is provided in the future, a supplemental report will be issued.
|
|
Event Description
|
It was reported that on: (b)(6) 2010: the patient was pre-operatively diagnosed with cervical stenosis and instability and underwent the following procedures: posterior c5-c6 bilateral laminectomy with fusion using synthes lateral mass screw system, bone morphogenic protein, spinal microdissection.As per op-notes, ¿bone morphogenic protein was then used to perform facet fusion after the area was decorticated.¿ no patient complications were reported.
|
|
Manufacturer Narrative
|
If information is provided in the future, a supplemental report will be issued.
|
|
Search Alerts/Recalls
|
|
|